Xiaofeng Xue

2.9k total citations
67 papers, 2.2k citations indexed

About

Xiaofeng Xue is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xiaofeng Xue has authored 67 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 26 papers in Cancer Research and 23 papers in Oncology. Recurrent topics in Xiaofeng Xue's work include MicroRNA in disease regulation (21 papers), Circular RNAs in diseases (16 papers) and Cancer-related molecular mechanisms research (12 papers). Xiaofeng Xue is often cited by papers focused on MicroRNA in disease regulation (21 papers), Circular RNAs in diseases (16 papers) and Cancer-related molecular mechanisms research (12 papers). Xiaofeng Xue collaborates with scholars based in China, United States and Japan. Xiaofeng Xue's co-authors include Qiaoming Zhi, Rongkuan Hu, Ling Gao, Lei Qin, Jishu Wei, Mingde Qin, Yi Miao, Xiaona Wang, Lin‐Hua Jiang and Hansi Liang and has published in prestigious journals such as Blood, PLoS ONE and Oncogene.

In The Last Decade

Xiaofeng Xue

64 papers receiving 2.1k citations

Peers

Xiaofeng Xue
Mihai Gagea United States
Xin Wu China
Aiping Luo China
Wantao Chen China
Xiqiang Liu China
Jinghuan Li China
Xin Xu China
Chunlin Ou China
Mihai Gagea United States
Xiaofeng Xue
Citations per year, relative to Xiaofeng Xue Xiaofeng Xue (= 1×) peers Mihai Gagea

Countries citing papers authored by Xiaofeng Xue

Since Specialization
Citations

This map shows the geographic impact of Xiaofeng Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofeng Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofeng Xue more than expected).

Fields of papers citing papers by Xiaofeng Xue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaofeng Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofeng Xue. The network helps show where Xiaofeng Xue may publish in the future.

Co-authorship network of co-authors of Xiaofeng Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaofeng Xue. A scholar is included among the top collaborators of Xiaofeng Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaofeng Xue. Xiaofeng Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xue, Xiaofeng, Zhiwei Li, Jiahui Zhao, et al.. (2025). Advances in the relationship between AP-1 and tumorigenesis, development and therapy resistance. Discover Oncology. 16(1). 61–61. 4 indexed citations
2.
3.
Zhu, Xiangcheng, Henan Li, Wei Zhang, et al.. (2025). Hydrogel Microspheres for Biomedical Applications. Small Science. 6(1). e202500453–e202500453.
4.
Wu, Kejia, Xiaojie Gan, Xiaofeng Xue, et al.. (2025). An interpretable machine learning model for predicting early liver metastasis after pancreatic cancer surgery. BMC Cancer. 25(1). 1117–1117. 1 indexed citations
5.
Zhang, Jinwei, Qian Liu, Xiaofeng Xue, et al.. (2024). Discovery of epigenetic modulators targeting HDACs and EZH2 simultaneously for the treatment of hematological malignancies. Bioorganic Chemistry. 153. 107964–107964. 5 indexed citations
6.
Cao, Pei, et al.. (2023). Gemcitabine Inhibits the Progression of Pancreatic Cancer by Restraining the WTAP/MYC Chain in an m6A-Dependent Manner. Cancer Research and Treatment. 56(1). 259–271. 6 indexed citations
7.
Zhou, Bin, et al.. (2022). Risk factors and survival prediction of pancreatic cancer with lung metastases: A population-based study. Frontiers in Oncology. 12. 952531–952531. 6 indexed citations
8.
Song, Sha, Fan Gao, Qi Li, et al.. (2021). IDH2 contributes to tumorigenesis and poor prognosis by regulating m6A RNA methylation in multiple myeloma. Oncogene. 40(35). 5393–5402. 28 indexed citations
9.
Gao, Ling, Tingting Xia, Mingde Qin, et al.. (2021). CircPTK2 Suppresses the Progression of Gastric Cancer by Targeting the MiR-196a-3p/AATK Axis. Frontiers in Oncology. 11. 706415–706415. 13 indexed citations
10.
Shi, Hao, Shan Huang, Mingde Qin, et al.. (2021). Exosomal circ_0088300 Derived From Cancer-Associated Fibroblasts Acts as a miR-1305 Sponge and Promotes Gastric Carcinoma Cell Tumorigenesis. Frontiers in Cell and Developmental Biology. 9. 676319–676319. 44 indexed citations
11.
Chen, Zhenlong, Daiwei Wan, Yilin Wang, et al.. (2019). Hsa_circ_101555 functions as a competing endogenous RNA of miR-597-5p to promote colorectal cancer progression. Oncogene. 38(32). 6017–6034. 73 indexed citations
12.
Xue, Xiaofeng, Xiaoyan Fei, Wenjie Hou, et al.. (2017). miR-342-3p suppresses cell proliferation and migration by targeting AGR2 in non-small cell lung cancer. Cancer Letters. 412. 170–178. 82 indexed citations
13.
Yuan, Bin, Hong Zhao, Xiaofeng Xue, et al.. (2016). Prognostic Value and Clinicopathological Differences of Bmi1 in Gastric Cancer: A Meta-analysis. Anti-Cancer Agents in Medicinal Chemistry. 16(4). 407–413. 7 indexed citations
14.
Wang, Gang, Zhihua Xu, Hong Zhao, et al.. (2016). Up-regulated Circulating miR-106a by DNA Methylation Promised a Potential Diagnostic and Prognostic Marker for Gastric Cancer. Anti-Cancer Agents in Medicinal Chemistry. 16(9). 1093–1100. 28 indexed citations
15.
Han, Ye, Xiaofeng Xue, Wei Li, et al.. (2015). Epidermal growth factor-like domain 7 promotes cell invasion and angiogenesis in pancreatic carcinoma. Biomedicine & Pharmacotherapy. 77. 167–175. 24 indexed citations
16.
Xue, Xiaofeng, Fei Liu, Ye Han, et al.. (2014). Silencing NPAS2 promotes cell growth and invasion in DLD-1 cells and correlated with poor prognosis of colorectal cancer. Biochemical and Biophysical Research Communications. 450(2). 1058–1062. 31 indexed citations
17.
Han, Ye, Xiaofeng Xue, Min Jiang, et al.. (2014). LGR5, a relevant marker of cancer stem cells, indicates a poor prognosis in colorectal cancer patients: A meta-analysis. Clinics and Research in Hepatology and Gastroenterology. 39(2). 267–273. 34 indexed citations
18.
Li, Qiang, Yong An, Nan Lv, et al.. (2013). CEACAM6 induces epithelial-mesenchymal transition and mediates invasion and metastasis in pancreatic cancer. International Journal of Oncology. 43(3). 877–885. 47 indexed citations
19.
Zhi, Qiaoming, Junjie Zhu, Xiaobo Guo, et al.. (2013). Metastasis-related miR-185 is a potential prognostic biomarker for hepatocellular carcinoma in early stage. Biomedicine & Pharmacotherapy. 67(5). 393–398. 40 indexed citations
20.
Tang, Dong, Zhongxu Yuan, Xiaofeng Xue, et al.. (2011). High expression of Galectin‐1 in pancreatic stellate cells plays a role in the development and maintenance of an immunosuppressive microenvironment in pancreatic cancer. International Journal of Cancer. 130(10). 2337–2348. 137 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mihai Gagea Breakdown of academic impact, for papers by Xin Wu Breakdown of academic impact, for papers by Aiping Luo Breakdown of academic impact, for papers by Wantao Chen Breakdown of academic impact, for papers by Xiqiang Liu Breakdown of academic impact, for papers by Jinghuan Li Breakdown of academic impact, for papers by Xin Xu Breakdown of academic impact, for papers by Chunlin Ou
Rankless by CCL
2026